The 206
patients in the study shared a number of characteristics, including stable, untreatable, age - related macular degeneration in both eyes with visual acuity no better than 20/80 but no worse than 20/800, along with good peripheral vision.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror
patient demand and may cause fluctuations
in Gilead's earnings; market
share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured
patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and
patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical
studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its
share repurchase program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
If one has never journeyed into the deep — prayed (which includes Scripture / theological
study, faith
sharing, adoration, spiritual formation / retreats, pilgramages, Mass, reconciliation, fasting, listening for God's voice, and more) on an ongoing fashion or done God's will (been obedient,
patient, humble, unconditionally sacrificing, unselfish) to the extent that they understand what it means to be Catholic and God being your number one priority — that His Ways and those of His Church are not the ways of the world (trade vices for virtues) and that we are being called into communion with Him via love for Him and one another
in our faith community and broader community — then it is no wonder some are lost or disillusioned.
«This is the first
study to look at the characteristics of women who are more or less likely to engage
in the practice of breast milk
sharing, and can help give physicians a starting point for dialogue with their
patients,» said Keim.
«The type of inflammation seen
in psoriasis is known to promote insulin resistance, and psoriasis and diabetes
share similar genetic mutations suggesting a biological basis for the connection between the two conditions we found
in our
study,» said the
study's senior author Joel M. Gelfand, MD MSCE, a professor of Dermatology and Epidemiology at Penn. «We know psoriasis is linked to higher rates of diabetes, but this is the first
study to specifically examine how the severity of the disease affects a
patient's risk.»
Over the
study period, they found that obese or morbidly obese
patients made up an increasing
share of knee dislocation
patients, rising to 19 percent of
patients in 2012 compared to just 8 percent
in 2000.
Dr Josie Billington, Deputy Researcher, Centre for Research into Reading, said: «Our
study indicated that
shared reading could potentially be an alternative to CBT
in bringing into conscious awareness areas of emotional pain otherwise passively suffered by chronic pain
patients.
Six years ago, Dr. Monje started to create and
share cell cultures of
patients» DIPG cells that could be
studied in labs.
«We have shown that a large number of
study participants are routinely exposed to the risks of trial participation without the benefits that
sharing and publishing results would have for
patients in the future.
In fact, in a review of 33 studies of patient use of audio - recorded clinical visits, the Open Recordings researchers found that 71 percent of patients listened to their recordings, while 68 percent shared them with a caregive
In fact,
in a review of 33 studies of patient use of audio - recorded clinical visits, the Open Recordings researchers found that 71 percent of patients listened to their recordings, while 68 percent shared them with a caregive
in a review of 33
studies of
patient use of audio - recorded clinical visits, the Open Recordings researchers found that 71 percent of
patients listened to their recordings, while 68 percent
shared them with a caregiver.
Their proposed «global alliance,» as they call it for now
in a white paper, aims to develop standards — analogous to protocols for building Internet web pages — that will enable researchers around the world
in fields from cancer to rare diseases to securely
share and
study patients» genome sequences and clinical information.
Other projects include an analysis of regional variations of cancer treatment
in Texas, a
study of the effect of smoking bans on hospitalization rates, and a
study of whether
shared savings programs for physicians can reduce overall
patient health care expenditures.
Results of the
study, which earlier this year won first prize
in the inaugural «PAN Challenge» for research on improving access to critical medications for Americans with chronic and rare diseases, showed that
patients in the latter, high - cost group were significantly less likely (45.3 percent vs. 66.9 percent) to have a Part D claim for a TKI prescription within six months of their CML diagnosis, compared to the subsidized, low cost -
sharing group.
Also as compared to more consistent reductions
in use of specialty drugs for rheumatoid arthritis, the review found that cost
sharing - still at modest levels during the period of these earlier
studies — had a lesser impact on
patients» use of cancer specialty drugs.
«Although almost all the prior
studies we reviewed were for privately insured
patients from a time when cost -
sharing levels were much lower than they are today, these
studies still commonly found evidence that high out - of - pockets costs were associated with reductions
in utilization of these drugs,» said Doshi.
$ 1.8 M Supports Cancer Drug Discovery on Commonly Mutated Gene New Brunswick Patch — April 5, 2016 Behavioral Scientist
Shares Insights about FDA's Proposed Rule on Banning Tanning Bed Use among Minors News-Medical.net - March 19, 2016 Intervention Program Reduces Caregiver Distress during Hospitalization of Pediatric Stem Cell Transplant
Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways
in the Development of Ovarian Cancer GMNews.com - March 2, 2016 Differences
in Type of Small Protein may further Elucidate Lung Cancer Risk
in African Americans ScienceDaily.com - March 2, 2016
Study Looks at Post-Treatment Resources for Prostate Cancer
Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the Line on Tanning Bed Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers
Study Uncovered about E-Cigarette Use NJBiz.com - December 9, 2015 Identification of Barrier that Prevents Progression of Benign Kidney Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color of the Lung Cancer Ribbon?
Patients from just over half of the families
in the
study appear to be
sharing a genetic factor at this locus, suggesting that it may be an important factor
in the onset of the condition.
Such
sharing raises the odds that two or more similar
patients with candidate genes
in common may be found, thereby allowing their condition to be more readily
studied and understood.
For example, we are able to explore the impact on transmission of
patient - to -
patient contact and
shared rooms, and to
study the effectiveness of
patient isolation
in lowering infection rates.
As a physician who interviewed women who had survived breast cancer for my art project The Woman Inside and who
studied patients who experienced spontaneous remissions from cancer as part of the research for my book Mind Over Medicine: Scientific Proof That You Can Heal Yourself, I discovered that those who had overcome cancer
shared one remarkable thing
in common.
Participants
in the
study then agreed to query
patients about the number and species of pets
in the home and requested that the
patient share their veterinarian's contact information.
Unlike our pilot
study, this
study included PCP training
in an expanded ADHD care management protocol, 1 practice - based randomization to optimize PCP participation, technology to collect and
share patient progress, and greater communication among CMs, PCPs, and families.
Group therapy for caregivers of
patients with cancer
in Western studies has been shown to be beneficial due to group processes of social comparison, information sharing and peer support.15 In Asia, the effectiveness of group therapy for caregivers of patients with cancer is unclear as research work in this area has largely been absen
in Western
studies has been shown to be beneficial due to group processes of social comparison, information
sharing and peer support.15
In Asia, the effectiveness of group therapy for caregivers of patients with cancer is unclear as research work in this area has largely been absen
In Asia, the effectiveness of group therapy for caregivers of
patients with cancer is unclear as research work
in this area has largely been absen
in this area has largely been absent.
The specific reasons for reduced depression
in patients exposed to
shared care are unclear and warrant further
study.